- Research article
- Open Access
Modulation of the human gut microbiota by dietary fibres occurs at the species level
© Chung et al. 2016
- Received: 21 September 2015
- Accepted: 23 December 2015
- Published: 11 January 2016
Dietary intake of specific non-digestible carbohydrates (including prebiotics) is increasingly seen as a highly effective approach for manipulating the composition and activities of the human gut microbiota to benefit health. Nevertheless, surprisingly little is known about the global response of the microbial community to particular carbohydrates. Recent in vivo dietary studies have demonstrated that the species composition of the human faecal microbiota is influenced by dietary intake. There is now potential to gain insights into the mechanisms involved by using in vitro systems that produce highly controlled conditions of pH and substrate supply.
We supplied two alternative non-digestible polysaccharides as energy sources to three different human gut microbial communities in anaerobic, pH-controlled continuous-flow fermentors. Community analysis showed that supply of apple pectin or inulin resulted in the highly specific enrichment of particular bacterial operational taxonomic units (OTUs; based on 16S rRNA gene sequences). Of the eight most abundant Bacteroides OTUs detected, two were promoted specifically by inulin and six by pectin. Among the Firmicutes, Eubacterium eligens in particular was strongly promoted by pectin, while several species were stimulated by inulin. Responses were influenced by pH, which was stepped up, and down, between 5.5, 6.0, 6.4 and 6.9 in parallel vessels within each experiment. In particular, several experiments involving downshifts to pH 5.5 resulted in Faecalibacterium prausnitzii replacing Bacteroides spp. as the dominant sequences observed. Community diversity was greater in the pectin-fed than in the inulin-fed fermentors, presumably reflecting the differing complexity of the two substrates.
We have shown that particular non-digestible dietary carbohydrates have enormous potential for modifying the gut microbiota, but these modifications occur at the level of individual strains and species and are not easily predicted a priori. Furthermore, the gut environment, especially pH, plays a key role in determining the outcome of interspecies competition. This makes it crucial to put greater effort into identifying the range of bacteria that may be stimulated by a given prebiotic approach. Both for reasons of efficacy and of safety, the development of prebiotics intended to benefit human health has to take account of the highly individual species profiles that may result.
- Colonic anaerobes
- Faecalibacterium prausnitzii
The human large intestine harbours up to 1014 bacteria, whose combined degradative and biochemical capabilities greatly exceed those of their host. The interplay between the host and its gut microbiota, via degradative activities that yield nutrients and metabolites and via interactions with the immune system, is highly complex, but the consequences for human health are increasingly recognised. Alterations in the gut environment and imbalances of intestinal homeostasis are associated with changes in microbiota composition during the development of gastrointestinal diseases , while microbiota composition is also thought to influence energy recovery from the diet, metabolic regulation, hormone signalling and systemic health [2, 3].
Although there is considerable variation in the gut microbiota even between healthy individuals, volunteer studies involving carefully controlled diets have now established that dietary intake exerts an important influence on the composition of the human gut microbiota [4–7]. These changes may reflect selective growth promotion by dietary components that provide the main energy sources for gut bacteria, as well as inhibitory effects resulting in particular from lipid intake and bile metabolism . Human diets provide energy sources available to the large intestinal microbiota mainly in the form of non-digestible (ND) carbohydrates (plant fibre and resistant starch). Studies in which ND carbohydrate intake was varied in diets with matching macronutrient composition have established that the type of ND carbohydrate can alter microbiota composition, and that such changes occur within a few days . Prebiotics based on ND carbohydrates, especially inulin and fructo-oligosaccharides, are already widely used with the aim of stimulating bacterial species and activities that are considered beneficial to health among the resident microbiota . Most studies on prebiotics have focussed on selected target groups rather than the whole microbial community, but these also provide evidence for the selective stimulation of certain groups or genera within the human gut microbiota [9, 10–11].
It is not possible to establish from in vivo studies whether changes in microbiota composition resulting from dietary supplementation with a ND carbohydrate are due to direct stimulation of growth by the substrate, or alternatively to indirect effects such as the acidification of the colon that follows the ingestion of any fermentable fibre due to subsequent generation of short chain fatty acids (SCFAs) by the microbiota [11, 12]. This question can, however, be answered in vitro by using anaerobic pH-controlled continuous flow fermentors inoculated with human faecal microbiota. In previous work, we showed that, with ND polysaccharides (mainly starch) as a growth substrate, a one unit pH shift caused a major change in composition of the human colonic microbiota, with Gram-negative Bacteroides species predominating at pH 6.5, but Gram-positive Firmicutes increasing at pH 5.5 [11, 13]. We decided to use this approach to determine to what extent different ND carbohydrates affect the composition of the gut microbiota at a given controlled pH. Specifically, the experiments reported here compare the impact of inulin and pectin upon the microbiota. Inulin is a plant storage polysaccharide that consists of linear chains of fructose residues with a β-(2–1) linkage and is the basis for many existing prebiotics. Pectin comprises a highly complex set of plant cell wall polysaccharides that includes homogalacturonan and rhamnogalacturonan I and II, with side chains of arabinans, galactans, and arabinogalactans . Our results show that inulin and pectin exert highly selective effects upon the gut microbiota not at the phylum level, but at the level of individual species, with very little overlap between the two substrates in the species promoted. Since pH is an important factor governing the competition between bacterial species  and luminal pH differs between the proximal and distal colon, it was important to obtain information across the physiologically relevant pH range. Responses are shown to be influenced quantitatively by the pH across the range 5.5–6.9. These findings have important consequences for our understanding of nutritional specialisation among human colonic bacteria and for predicting how diet composition, including the addition of prebiotics, can be used to manipulate microbiota composition.
Influence of pH on competition for inulin and apple pectin in continuous culture
Impact of pH changes
With pectin as a substrate, pH again had a significant effect on the percentage of Bacteroidetes sequences (ANOVA P = 0.0068); for this substrate, however, an increase in percentage Bacteroidetes sequences between pH 5.5 and pH 6.9 was seen only for the F2 downshift fermentors (P = 0.001) and not for the F1 upshift fermentors (Fig. 2e). Possible explanations for this intriguing effect of pH order are considered in the Discussion. Sequence analysis did not show a significant effect of pH upon percentage Firmicutes or Proteobacteria sequences for either substrate, although qPCR indicated a significant decrease in Lachnospiraceae between pH 5.5 and 6.9 with inulin as a substrate in F1 fermentors (Fig. 2c).
Responses at the operational taxonomic unit (OTU) level
Interspecies competition within individual microbiota
The situation was more complex in the pectin-fed fermentors. B. vulgatus/dorei was apparently co-dominant with B. eggerthii in the D1 fermentors, with B. cellulosilyticus/intestinalis in the D2 fermentors and with B. stercoris in the D3 fermentors, with some indication of co-existence of co-dominant species at the same time-points. While B. vulgatus/dorei was detected in inocula from all three donors, B. stercoris and B. thetaiotaomicron were detected only in D3 and B. eggerthii and B. cellulosilyticus/intestinalis were not detected in D3 and D1 inocula, respectively. Thus, the emergence of different co-dominant OTUs appears to reflect the variable abundance of different Bacteroides species and strains in the inocula (Fig. 5, legend). Eubacterium eligens was able to compete with the Bacteroides species for pectin at certain pH values in all experiments, but was particularly successful in experiments with the D2 inoculum. In some of the downshift (F2) fermentors the dominance of the Bacteroides spp. was clearly curtailed or abolished at pH 5.5, and this was mirrored by a sharp increase in the abundance of F. prausnitzii OTUs at this pH. This phenomenon can be seen for D1_F2_Inulin, D2_F2_Inulin, and D1_F2_Pectin (Fig. 5d, e, j).
Targeted qPCR detection of selected groups (Fig. 2a–d) and species (Additional file 5: Figure S2, Additional file 6: Figure S3) further confirmed the findings obtained from amplicon sequencing. E. eligens was undetectable in inulin fermentors but was prominent in pectin fermentors, especially for D2, while the increase in F. prausnitzii, noted above, in certain fermentor communities at particular time points was again apparent (Additional file 5: Figure S2, Additional file 6: Figure S3).
Impacts on community diversity
Short chain fatty acids (SCFA)
Several different approaches can be employed to understand and predict the selective influence of ND carbohydrates upon the gut microbiota. Analysis of carbohydrate active enzyme (CAZyme, Carbohydrate Active Enzymes database [16, 17], URL http://www.cazy.org/) complements from individual genomes  and growth tests on isolated species  may be indicative, but cannot predict how different organisms will compete and interact within the complex intestinal community. At the other extreme, in vivo feeding experiments cannot readily distinguish effects mediated via the gut environment, for example, changes in gut transit or pH, from the direct selective effects of the substrate. Furthermore, in vivo nutritional studies do not provide precise control over the substrates available to the microbiota, since endogenous substrates such as mucin and other food components will always be present. The approach that we have adopted here of using in vitro continuous flow fermentors to study the human intestinal microbiota as a microcosm has the considerable advantage of allowing precise control over both substrate supply and pH.
Detailed investigations into polysaccharide utilization have so far been mainly undertaken for Bacteroides spp. among predominant human gut anaerobes , although more recently studies have also been conducted in the Firmicutes representative Eubacterium rectale . In Bacteroides spp., genes responsible for the degradation of particular polysaccharides are organized at polysaccharide utilization loci (PULs) that also encode transport functions and transcriptional regulators. Individual Bacteroides genomes typically possess large numbers of PULs (over 80) that are concerned with degradation of different host- and diet-derived polysaccharides [22, 23]. Variations in PUL distribution between species have been demonstrated to correlate with the ability to utilize particular polysaccharides in vitro and in gnotobiotic animal models [23–25]. Our results show that all of the eight most abundant Bacteroides OTUs present in the initial faecal microbiota gave a strong differential response in the mixed fermentor communities, being stimulated either by inulin (in two cases) or by pectin (in six cases). Similar selectivity was evident for many Firmicutes. Among the top 38 OTUs (each representing 0.5 % or more of the total sequences), five Firmicutes OTUs increased in abundance with inulin, while a further five Firmicutes OTUs increased with pectin (Additional files 3 and 4: Tables S2 and S3).
Previous studies on cultured isolates indicated that pectin utilization is widespread among Bacteroides spp., but relatively uncommon among human colonic Firmicutes [26, 27]. Nevertheless, the strong and highly specific enrichment of the pectin-utilizing Firmicutes species E. eligens [26, 27] could provide the basis for an effective prebiotic strategy while enrichment of one F. prausnitzii OTU by pectin was also observed here. Inulin stimulated the Firmicutes species F. prausnitzii and A. hadrus (strains related to the isolate SS2/1) as has also been reported in an in vivo human study [10, 15]. Both species are butyrate-producing bacteria that offer potential benefits to health, via anti-inflammatory action in the case of F. prausnitzii , and via conversion of D-lactate to butyrate in the case of A. hadrus [29, 30]. In addition to promoting particular Bacteroidetes and Firmicutes OTUs, inulin also promoted some Proteobacteria, including Sutterella wadsworthensis. This may warrant further investigation as S. wadsworthensis has been isolated not only from healthy individuals but also from gastrointestinal disease states .
Many studies have shown that inulin has a bifidogenic effect in vivo [9, 32–34] and there is also a report suggesting that pectin can be bifidogenic . Interestingly, we found no evidence in these experiments for an overall stimulation of bifidobacteria by inulin or pectin either from sequence analysis, even though B. pseudocatenulatum was detected as one of the 10 most abundant OTUs, or from qPCR monitoring of the Bifidobacterium genus. Since the representation of bifidobacteria was greatest at pH 5.5 in the inulin fermentors (Fig. 7), it therefore seems likely that the promotion of bifidobacteria by inulin that is observed in vivo depends critically on acidification in the colonic lumen that results from SCFA production . At pH values closer to neutrality our evidence suggests that other bacteria will tend to out-compete bifidobacteria for inulin. It is also known that the chain length of inulin is critical in determining its utilization by isolated gut anaerobes , which can complicate the comparison of different studies. Many isolated bifidobacteria cannot utilize long chain inulin, although they are able to benefit from fructo-oligosaccharide breakdown products via cross-feeding in co-cultures . In general, metabolic cross-feeding involving partial degradation products, fermentation products and growth factors, but also inhibitory interactions, can be expected to have played a role in the community changes occurring in these studies [37, 38].
The overall decrease in microbiota diversity in the fermentor community relative to the faecal inoculum (seen from Fig. 6) is assumed to result mainly from the supply of a single substrate as energy source. By contrast, typical human diets supply a very wide variety of types of fibre and a wide array of host-derived glycans and proteins (especially mucins). Another important factor is likely to be the relative stability of conditions within the fermentor compared with the fluctuations that occur in vivo as a result of periodic meals.
Our experiments also show that pH exerts a strong influence on competition between bacteria from different phyla or families that share the ability to utilize the same polysaccharide. This effect was particularly clear for the inulin fermentors, where the proportion of Bacteroidetes 16S rRNA gene copies fell from around 60 % at pH 6.9 to around 30 % at pH 5.5. This suppression of Bacteroides spp. at slightly acidic pH appears to reflect growth inhibition by SCFAs at pH values below 6 [11, 13]. Interestingly, this trend was not evident for the pectin upshift fermentors where E. eligens was apparently able to compete with pectin-utilizing Bacteroides spp. across the pH range. The correlation between Bacteroides representation in the community and the proportion of propionate that was seen here has also been noted for faecal samples from an in vivo study . This is assumed to reflect the dominant role of the succinate pathway, which is found mainly in the Bacteroidetes among human colonic bacteria, in the formation of propionate from carbohydrates . Thus, there was considerable functional redundancy with respect to propionate formation, as substrate-driven changes in the dominant species of Bacteroidetes appeared to have little influence. On the other hand, the species level changes seen here could potentially have many other effects on the host, including those via immune signalling and metabolite transformation and which will warrant investigation in future studies.
We observed some asymmetry in the response of the microbial community to low pH in parallel downshift and upshift fermentors that received the same inoculum. A possible explanation for this lies in the initial reduction in community diversity in the fermentors, discussed above. Theoretical modelling suggests that diversity will also have decreased at the strain level as strains that have optimal characteristics for pH tolerance and substrate utilization are selected . Thus, the community at the start of the pH 5.5 phase in the downshift fermentors was considerably less diverse than the inoculum that initiated the pH 5.5 phase (P <0.005) in the upshift fermentors. This lower diversity may have led to the absence of Bacteroides strains tolerant of pH 5.5 at the end of the downshift runs, thus allowing the growth of more low-pH tolerant competitors such as F. prausnitzii [27, 40] and perhaps explaining the observed ‘blooms’ in F. prausnitzii that were seen in several fermentor runs (Fig. 5). Interestingly, sudden shifts in the ratio of Bacteroides to F. prausnitzii have also been reported in vivo in human subjects .
In summary, we have shown that two ND carbohydrates, inulin and pectin, promote very different community profiles when supplied as sole energy sources to human colonic microbial communities under conditions of controlled pH and turnover. Notably, these differences were found to lie at the species level rather than at the phylum or family level. We found very little overlap between the species stimulated by the two substrates, implying that evolution in the highly competitive environment of the large intestinal microbiota has favoured a high degree of nutritional niche specialization at the species level. At the same time, it is evident that a number of phylogenetically distant organisms belonging to different phyla have evolved convergently to gain the ability to utilize the same substrates. With a simple homopolymer (inulin) as a substrate, a single species was found to dominate the community at a given pH, but several species were apparently able to co-exist on pectin at the same pH. It is likely that the extreme chemical complexity of pectin  creates multiple nutritional niches which can explain the greater microbiota diversity seen in the pectin-fed relative to the inulin-fed communities. Our experiments also show that the species that become dominant with a given substrate can vary for individual microbial communities, and are likely to depend on the precise mix of competing strains within each microbiota.
In view of these and other recent findings, dietary manipulation through supplementation with ND carbohydrates has considerable potential for modifying the composition of the human colonic microbiota, with the aim of benefiting health. However, our findings show that it is crucial to define the profile of bacterial species promoted by an intended prebiotic, as even closely related species within the human colonic microbiota have evolved distinct substrate preferences. Bacterial populations that become promoted are likely to include species from outside the group originally targeted, and may potentially include harmful as well as beneficial organisms and also species whose effects on the host are unknown. Our work also provides a compelling rationale for pursuing ‘synbiotic’ approaches, whereby prebiotic substrates are specifically matched with beneficial microbes that are capable of utilizing them in order to enhance their colonization and activities in vivo. This could involve specific combinations of prebiotics and probiotics, or target populations of resident bacteria. First, however, it is necessary to identify which species within the complex gut microbiota are likely to respond to a given dietary manipulation. The approaches described here can thus help us to focus the necessary research into the health consequences of dietary manipulation to the most relevant bacterial species.
Simulated human colonic fermentor studies
Two single-stage fermentor systems, with a working volume of 250 mL, were set-up as described previously using a medium based on that of Macfarlane et al. , containing 0.6 % (w/v) peptide . In the present experiments, however, the only added carbohydrate energy source was either apple pectin (Sigma) or inulin (Oliggo-Fiber DS2, avDP <10, Cargill Inc.) at 0.5 % (w/v). The fermentor culture vessels were maintained under a stream of CO2 at a constant temperature of 37 °C using a thermal jacket. Both the medium reservoir and fermentor culture vessel were mixed by internal stirrer bars powered by external stirring units. The volume of the culture was kept constant at 250 mL with a constant flow of fresh medium at a turnover of 250 mL/day. A SCFA mix was added initially in the apple pectin fermentors, containing 33 mM acetate, 9 mM propionate and 1 mM each of iso-butyrate, iso-valerate and valerate. The pH of the fermentor vessels were monitored and controlled using a pH controller that delivers either 0.1 M HCl or 0.1 M NaOH solutions to maintain the pH at 5.5 ± 0.2, 6.0 ± 0.2, 6.4 ± 0.2 and 6.9 ± 0.2 for a period of 3 days at each pH. One fermentor vessel (fermentor 1) started from the low pH (5.5) at day 0 with pH increasing over time (upshift) (Fig. 1). The other (fermentor 2) started from the highest pH (6.9) at day 0 with pH decreasing over time (downshift). Inocula were from fresh faecal samples and were prepared by mixing 5 g of faeces in 10 mL of 50 mM phosphate buffer (pH 6.5) under O2 free CO2 containing 0.05 % cysteine, using gentle MACS™ M Tubes (MACS Miltenyl Biotec). Faecal samples were donated by three healthy adult volunteers who had no history of colonic disease and had consumed no drugs known to influence the microbiota for at last 3 months prior to the sampling date. All volunteers were omnivores, one male (64 years old) and two female (53 and 42 years old).
Each fermentor sample collected was immediately processed using the FastDNA Spin kit (MP Biomedicals). The samples (460 μL) were placed in lysing matrix E tubes and 978 μL of sodium phosphate buffer and 122 μL MT buffer were added to each tube, which was processed following the manufacturer’s instructions. The DNA was eluted in 50 μL FastPrep elution buffer. Faecal DNA was quantified by Nanodrop mass spectrophotometry.
PCR amplification and Illumina MiSeq sequencing
The extracted DNA was used as a template for PCR amplification of the V1-V2 region of bacterial 16S rRNA genes using the barcoded fusion primers MiSeq-27F (5′-AATGATACGGCGACCACCGAGATCTACACTATGGTAATTCCAGMGTTYGATYMTGGCTCAG-3′) and MiSeq-338R (5′-CAAGCAGAAGACGGCATACGAGAT-barcode-AGTCAGTCAGAAGCTGCCTCCCGTAGGAGT-3′), which also contain adaptors for downstream Illumina MiSeq sequencing. Each of the samples was amplified with a unique (12 base) barcoded reverse primer.
Initial PCR amplification was undertaken with New England BioLabs Q5 High-fidelity DNA Polymerase, utilizing a per-reaction mix of DNA template (1 μL), 5X Q5 Buffer (5 μL), 10 mM dNTPs (0.5 μL), 10 μM F Primer (1.25 μL), 10 μM R Primer (1.25 μL), Q5 Taq (0.25 μL) and sterile, deionised water (15.75 μL) to a final volume of 20 μL. PCR cycling conditions were as follows: 2 minutes at 98 °C; 20 cycles of 30 s at 98 °C, 30 s at 50 °C, 120 s at 72 °C; end with 5 mins at 72 °C then holding temperature at 10 °C. Quadruplicate PCR reactions per DNA sample were set up. Following confirmation of adequate and appropriately sized products, the quadruplicate reactions were pooled and ethanol precipitated. The pooled amplicons were then quantified using a Qubit 2.0 Fluorometer (Life Technologies Ltd) and a sequencing mastermix was created using equimolar concentrations of DNA from each sample. Sequencing was carried out on an Illumina MiSeq machine, using 2 × 250 bp read length, at the Wellcome Trust Sanger Institute (Cambridgeshire, UK). Sequence data has been deposited in the European Nucleotide Archive and is available under study accession number ERP010892, and sample accession numbers ERS782738 to ERS782828 (Additional file 2: Table S1).
The data obtained from Illumina MiSeq sequencing was analyzed using the mothur software package  and their MiSeq SOP . Forward and reverse reads generated by sequencing were assembled into paired read contigs. Resulting contigs that were shorter than 270 bp, longer than 480 bp, contained ambiguous bases, or contained homopolymeric stretches of longer than 7 bases, were all removed. Unique sequences were then grouped together and aligned against the SILVA reference database. Pre-clustering (diffs = 3) was carried out to reduce the impact of sequencing errors and the OTUs were generated at a 97 % similarity cut-off level. Taxonomic classifications for each OTU from phylum to genus level were assigned using the RDP reference database (release 10) . To assign species-level classifications, representative sequences for each OTU were generated using the “get.oturep” command in mothur and then searched against the NCBI Nucleotide database using MegaBLAST. Species-level classifications were assigned to OTUs where there was a greater than 99 % similarity to a reference sequence derived from a cultured isolate, and no similarity at greater than 97 % to any other cultured species in order to allow for the 3 % variation within each OTU. For OTUs where there were more than one species within a 3 % similarity margin “spp.” or multiple species names were used to indicate that we could be capturing more than one characterized species within a given OTU. Chimeric molecules created during PCR amplification as well as reads from chloroplast, mitochondria, archaea, eukaryote and unknown sequences were removed from the dataset . The resulting dataset had a total of 1,721,766 sequences with a range of 8767–27679 sequences per sample. All samples were rarefied to 8767 to ensure equal sequencing depth for all comparisons. The final OTU-level results are shown in Additional file 2: Table S1. Metastats analysis  was used to determine any OTUs that were significantly different between two sample cohorts, and P values were corrected with the Benjamini-Hochberg method  to allow for the false discovery rate over multiple comparisons. In addition, significant differences across all cohorts were identified using LEfSe analysis . The Shannon diversity index and inverse Simpson diversity index were used to calculate bacterial diversity per sample.
Quantitative real-time PCR (qPCR)
qPCR was performed in duplicate with iTaqTM Universal SYBR® Green Supermix (Bio-Rad) in a total volume of 10 μL with primers at 500 nM and 5 ng of DNA in optical-grade 384-well plates sealed with optical sealing tape. Amplification was performed with a CFX384TM Real-time System (Bio-Rad) with the following protocol: one cycle of 95 °C for 3 min, 40 cycles of 95 °C for 5 s and annealing temperature as per Additional file 9: Table S5 for 30 s, 1 cycle of 95 °C for 10 s, and a stepwise increase of the temperature from 65 °C to 95 °C (at 5 s per 0.5 °C) to obtain melt curve data. As described previously , standard curves consisted of 10-fold dilution series of amplified bacterial 16S rRNA genes from reference strains. Samples were amplified with universal primers against total bacteria and specific primers against Bifidobacterium spp., Bacteroides spp., Prevotella spp., Clostridial cluster XIVa spp. (Lachnospiraceae), F. prausnitzii, A. hadrus, E. eligens and E. rectale/Roseburia spp. (Additional file 9: Table S5). The abundance of 16S rRNA genes was determined from standard curves and specific bacterial groups were expressed as a percentage of total bacteria as determined by the universal primers. The detection limit was determined with negative controls containing only herring sperm DNA. qPCR were performed in duplicates and the data were analysed using BioRad CFX manager software.
Short chain fatty acid (SCFA) analysis
SCFA formation was assessed in fermentor samples by gas chromatography as described previously . Briefly, following derivatisation of the samples using N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide, the samples were analysed using a Hewlett Packard gas chromatograph fitted with a fused silica capillary column with helium as the carrier gas.
SCFA, MiSeq and qPCR data from these experiments were analysed by ANOVA with donor, fermentor, and donor and time within fermentor as random effects, and with pH, run (upshift or downshift), and their interaction as fixed effects. When an effect was significant (P <0.05) mean values were then compared by post-hoc t-test based on the output from the ANOVA analysis.
We would like to thank Donna Henderson for carrying out GC analysis, and Paul Scott, Iraad Bronner and the Wellcome Trust Sanger Institute’s core sequencing team for carrying out the Illumina MiSeq sequencing of 16S rRNA genes. We are grateful to Grietje Holtrop (BioSS) for advice on statistical analysis. Freda Farquharson kindly contributed her expertise with training on qPCR. The Rowett Institute of Nutrition and Health receives financial support from the Scottish Government Rural and Environmental Sciences and Analytical Services (RESAS) and this work was partly funded by the Biotechnology and Biological Sciences Research Council (BBSRC-CASE) and Cargill, Inc. AWW, JP and 16S rRNA gene sequencing costs were funded by the Wellcome Trust (grant number 098051).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474(7351):298–306.View ArticlePubMedGoogle Scholar
- Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541–6.View ArticlePubMedGoogle Scholar
- Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9(10):577–89.View ArticlePubMedGoogle Scholar
- Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011;5(2):220–30.PubMed CentralView ArticlePubMedGoogle Scholar
- David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–63.PubMed CentralView ArticlePubMedGoogle Scholar
- Salonen A, Lahti L, Salojärvi J, Holtrop G, Korpela K, Duncan SH, et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J. 2014;8(11):2218–30.View ArticlePubMedGoogle Scholar
- Martínez I, Lattimer JM, Hubach KL, Case JA, Yang J, Weber CG, et al. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 2013;7(2):269–80.PubMed CentralView ArticlePubMedGoogle Scholar
- Macfarlane GT, Macfarlane S. Fermentation in the human large intestine its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol. 2011;45:S120–7.View ArticlePubMedGoogle Scholar
- Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourie B, et al. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose–response relation study. Am J Clin Nutr. 2004;80(6):1658–64.PubMedGoogle Scholar
- Ramirez Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr. 2009;101(4):541–50.View ArticlePubMedGoogle Scholar
- Duncan SH, Louis P, Thomson JM, Flint HJ. The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol. 2009;11(8):2112–22.View ArticlePubMedGoogle Scholar
- Bown RL, Gibson JA, Sladen GE, Hicks B, Dawson AM. Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device. Gut. 1974;15(12):999–1004.PubMed CentralView ArticlePubMedGoogle Scholar
- Walker AW, Duncan SH, Leitch E, Child MW, Flint HJ. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol. 2005;71(7):3692–700.PubMed CentralView ArticlePubMedGoogle Scholar
- Schols HA, Voragen AGJ. Complex pectins: structure elucidation using enzymes. Prog Biotechnol. 1996;14:3–19.View ArticleGoogle Scholar
- Louis P, Young P, Holtrop G, Flint HJ. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol. 2010;12(2):304–14.View ArticlePubMedGoogle Scholar
- Cantarel BI, Coutinho PM, Rancurel C, Bernard T, Lombard V, Henrissat B. The Carbohydrate-Active EnZymes database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res. 2009;37 Suppl 1:D233–8.PubMed CentralView ArticlePubMedGoogle Scholar
- Lombard V, Golaconda Ramulu H, Drula E, Coutinho PM, Henrissat B. The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res. 2014;42(D1):D490–5.PubMed CentralView ArticlePubMedGoogle Scholar
- Kaoutari AE, Armougom F, Gordon JI, Raoult D, Henrissat B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat Rev Microbiol. 2013;11(7):497–504.View ArticlePubMedGoogle Scholar
- Scott KP, Martin JC, Duncan SH, Flint HJ. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria in vitro. FEMS Microbiol Ecol. 2014;87(1):30–40.View ArticlePubMedGoogle Scholar
- Martens EC, Koropatkin NM, Smith TJ, Gordon JI. Complex glycan catabolism by the human gut microbiota: the bacteroidetes sus-like paradigm. J Biol Chem. 2009;284(37):24673–7.PubMed CentralView ArticlePubMedGoogle Scholar
- Cockburn DW, Orlovsky NI, Foley MH, Kwiatkowski KJ, Bahr CM, Maynard M, et al. Molecular details of a starch utilization pathway in the human gut symbiont Eubacterium rectale. Mol Microbiol. 2015;95(2):209–30.PubMed CentralView ArticlePubMedGoogle Scholar
- Ravcheev DA, Godzik A, Osterman AL, Rodionov DA. Polysaccharides utilization in human gut bacterium Bacteroides thetaiotaomicron: comparative genomics reconstruction of metabolic and regulatory networks. BMC Genomics. 2013;14:1.View ArticleGoogle Scholar
- Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, Bolam DN, et al. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell. 2010;141(7):1241–52.PubMed CentralView ArticlePubMedGoogle Scholar
- Sonnenburg JL, Xu J, Leip DD, Chen C, Westover BP, Weatherford J, et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science. 2005;307(5717):1955–9.View ArticlePubMedGoogle Scholar
- Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci U S A. 2009;106(14):5859–64.PubMed CentralView ArticlePubMedGoogle Scholar
- Salyers AA, West SEH, Vercellotti JR, Wilkins TD. Fermentation of mucins and plant polysaccharides by anaerobic bacteria from human colon. Appl Environ Microbiol. 1977;34(5):529–33.PubMed CentralPubMedGoogle Scholar
- Lopez-Siles M, Khan TM, Duncan SH, Harmsen HJM, Garcia-Gil LJ, Flint HJ. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol. 2012;78(2):420–8.PubMed CentralView ArticlePubMedGoogle Scholar
- Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux J, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105(43):16731–6.PubMed CentralView ArticlePubMedGoogle Scholar
- Allen-Vercoe E, Daigneault M, White A, Panaccione R, Duncan SH, Flint HJ, et al. Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976. Anaerobe. 2012;18(5):523–9.View ArticlePubMedGoogle Scholar
- Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol. 2004;70(10):5810–7.PubMed CentralView ArticlePubMedGoogle Scholar
- Mukhopadhya I, Hansen R, Nicholl CE, Alhaidan YA, Thomson JM, Berry SH, et al. A comprehensive evaluation of colonic mucosal isolates of Sutterella wadsworthensis from inflammatory bowel disease. PLoS ONE. 2011;6(10):e27076.PubMed CentralView ArticlePubMedGoogle Scholar
- Bouhnik Y, Raskine L, Champion K, Andrieux C, Penven S, Jacobs H, et al. Prolonged administration of low-dose inulin stimulates the growth of bifidobacteria in humans. Nutr Res. 2007;27(4):187–93.View ArticleGoogle Scholar
- Meyer D, Stasse-Wolthuis M. The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr. 2009;63(11):1277–89.View ArticlePubMedGoogle Scholar
- Costabile A, Kolida S, Klinder A, Gietl E, Buerlein M, Frohberg C, et al. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr. 2010;104(7):1007–17.View ArticlePubMedGoogle Scholar
- Olano-Martin E, Gibson GR, Rastall RA. Comparison of the in vitro bifidogenic properties of pectins and pectic-oligosaccharides. J Appl Microbiol. 2002;93(3):505–11.View ArticlePubMedGoogle Scholar
- Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol. 2006;72(5):3593–9.PubMed CentralView ArticlePubMedGoogle Scholar
- Duncan SH, Scott KP, Ramsay AG, Harmsen HJM, Welling GW, Stewart CS, et al. Effects of alternative dietary substrates on competition between human colonic bacteria in an anaerobic fermentor system. Appl Environ Microbiol. 2003;69(2):1136–42.PubMed CentralView ArticlePubMedGoogle Scholar
- Flint HJ, Duncan SH, Scott KP, Louis P. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol. 2007;9(5):1101–11.View ArticlePubMedGoogle Scholar
- Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP, et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 2014;8(6):1323–35.PubMed CentralView ArticlePubMedGoogle Scholar
- Kettle H, Donnelly R, Flint HJ, Marion G. pH feedback and phenotypic diversity within bacterial functional groups of the human gut. J Theor Biol. 2014;342:62–9.View ArticlePubMedGoogle Scholar
- Lahti L, Salojärvi J, Salonen A, Scheffer M, De Vos WM. Tipping elements in the human intestinal ecosystem. Nat Commun. 2014;5:4344.PubMed CentralView ArticlePubMedGoogle Scholar
- Voragen AGJ, Coenen G, Verhoef RP, Schols HA. Pectin, a versatile polysaccharide present in plant cell walls. Struct Chem. 2009;20(2):263–75.View ArticleGoogle Scholar
- MacFarlane GT, Hay S, Gibson GR. Influence of mucin on glycosidase, protease and arylamidase activities of human gut bacteria grown in a 3-stage continuous culture system. J Appl Bacteriol. 1989;66(5):407–17.View ArticlePubMedGoogle Scholar
- Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537–41.PubMed CentralView ArticlePubMedGoogle Scholar
- Kozich J, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the miseq illumina sequencing platform. Appl Environ Microbiol. 2013;79(17):5112–20.PubMed CentralView ArticlePubMedGoogle Scholar
- Wang Q, Garrity GM, Tiedje JM, Cole JR. Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261–67.PubMed CentralView ArticlePubMedGoogle Scholar
- Quince C, Lanzen A, Davenport RJ, Turnbaugh PJ. Removing noise from pyrosequenced amplicons. BMC Bioinform. 2011;12:38.View ArticleGoogle Scholar
- White JR, Nagarajan N, Pop M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol. 2009;5(4):e1000352.PubMed CentralView ArticlePubMedGoogle Scholar
- Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289–300.Google Scholar
- Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:6.View ArticleGoogle Scholar
- Richardson AJ, Calder AG, Stewart CS, Smith A. Simultaneous determination of volatile and non-volatile acidic fermentation products of anaerobes by capillary gas chromatography. Lett Appl Microbiol. 1989;9(1):5–8.View ArticleGoogle Scholar